U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C23H29N3O2.ClH
Molecular Weight 415.956
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXYPERTINE HYDROCHLORIDE

SMILES

Cl.COC1=C(OC)C=C2C(NC(C)=C2CCN3CCN(CC3)C4=CC=CC=C4)=C1

InChI

InChIKey=USAPVNXIZYFWLO-UHFFFAOYSA-N
InChI=1S/C23H29N3O2.ClH/c1-17-19(20-15-22(27-2)23(28-3)16-21(20)24-17)9-10-25-11-13-26(14-12-25)18-7-5-4-6-8-18;/h4-8,15-16,24H,9-14H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula C23H29N3O2
Molecular Weight 379.4953
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Oxypertine (Equipertine, Forit, Integrin, Lanturil, Lotawin, Opertil) is a neuroleptic drug and was originally introduced as a treatment for schizophrenia in the 1960s. Oxypertine is an indole derivative with general properties similar to those of the phenothiazine, chlorpromazine. It has been given by mouth in the treatment of various psychoses including schizophrenia, mania, and disturbed behaviour, and of severe anxiety. Like reserpine and tetrabenazine, oxypertine depletes catecholamines, though not serotonin, possibly underlying its neuroleptic efficacy. The molecular structure is strongly similar to solypertine and milipertine.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
54.0 nM [IC50]
210.0 nM [IC50]
25.0 nM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
FORIT
Primary
FORIT

AUC

ValueDoseCo-administeredAnalytePopulation
34 μg × min/mL
25 mg/kg single, oral
1-PHENYLPIPERAZINE plasma
Rattus norvegicus

Doses

PubMed

Sample Use Guides

In Vivo Use Guide
Oxypertine 20 mg given orally as a nocturnal sedative and again on the morning of operation produced relief of anxiety
Route of Administration: Oral
In Vitro Use Guide
Oxypertine inhibited [3H]WB-4101 binding in rat cerebral cortex membranes with IC50 54 nM
Substance Class Chemical
Record UNII
9P131473P6
Record Status Validated (UNII)
Record Version